✦ LIBER ✦

Evaluation of WO2013116562A, an orally active PI3Kδ inhibitor for the treatment of asthma

✍ Scribed by Norman, Peter

Book ID: 126904227
Publisher: Informa plc
Year: 2014
Tongue: English
Weight: 367 KB
Volume: 24
Category: Article
ISSN: 1354-3776
DOI: 10.1517/13543776.2014.870155

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of WO2012037204 and WO2012037

Evaluation of WO2012037204 and WO2012037226: Exelixis' selective PI3Kδ inhibitors; the basis of a US$251 million deal

✍ Norman, Peter 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 317 KB

Captopril, an Orally Active Converting E

Captopril, an Orally Active Converting Enzyme Inhibitor, in the Treatment of Primary Hypertension

✍ Karlberg, Bengt E. ;Asplund, Johan ;Nilsson, Ove R. ;Wettre, Staffan ;Öhman, K. 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) ⚖ 656 KB

Discovery of an orally active subtype-se

Discovery of an orally active subtype-selective HDAC inhibitor, chidamide, as an epigenetic modulator for cancer treatment

✍ Pan, De-Si; Yang, Qian-Jiao; Fu, Xin; Shan, Song; Zhu, Jing-Zhong; Zhang, Kun; L 📂 Article 📅 2014 🏛 The Royal Society of Chemistry 🌐 English ⚖ 841 KB

Roflumilast: the new orally active, sele

Roflumilast: the new orally active, selective phophodiesterase-4 inhibitor, for the treatment of COPD

✍ Tashkin, Donald P 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 467 KB

Development of a Scalable Strategy for t

Development of a Scalable Strategy for the Synthesis of PI3Kδ Inhibitors: Selective and Efficient Functionalization of Purine Derivatives

✍ Carrera, Diane E.; Sheng, PeiJue; Safina, Brian S.; Li, Jun; Angelaud, Remy 📂 Article 📅 2013 🏛 American Chemical Society 🌐 English ⚖ 435 KB

VS-5584, a Novel and Highly Selective PI

VS-5584, a Novel and Highly Selective PI3K/mTOR Kinase Inhibitor for the Treatment of Cancer

✍ Hart, S.; Novotny-Diermayr, V.; Goh, K. C.; Williams, M.; Tan, Y. C.; Ong, L. C. 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 971 KB